Also trades as: 7777.T (JPX) · $vol 7M

$2.70

+0.10 (+3.72%)

OTC · Healthcare · Biotechnology · Tech Score Buy · Power 67 · $345.5M mcap · 118M float · 0.0001% daily turnover · Short 100% of daily vol

Revenue

$10.9B +56.7% ▲

5Y CAGR: +60.4%

Gross Profit

$8.6B +93.4% ▲

5Y CAGR: +94.8%

Operating Income

$1.3B +215.3% ▲

Net Income

$4.1B +265.9% ▲

EPS (Diluted)

$31.28 +224.1% ▲

EBITDA

$1.3B +155.5% ▲

5Y CAGR: +15.9%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$1.5B	$2.3B	$4.6B	$6.9B	$10.9B
YoY Growth	+47.0%	+53.6%	+98.3%	+51.1%	+56.7%
Cost of Revenue	$845M	$1.0B	$1.5B	$2.5B	$2.3B
Gross Profit	$661M	$1.3B	$3.1B	$4.4B	$8.6B
Gross Margin	43.9%	55.7%	67.3%	63.8%	78.7%
R&D Expenses	$685M	$452M	$556M	$498M	$639M
SG&A Expenses	$2.7B	$4.0B	$4.6B	$5.1B	$6.6B
Operating Expenses	$3.4B	$4.4B	$5.2B	$5.6B	$7.2B
Operating Income	-$2.7B	-$3.2B	-$2.1B	-$1.2B	$1.3B
Operating Margin	-181.7%	-136.5%	-46.1%	-16.7%	12.3%
Interest Expense	$5M	$61M	$84M	$74M	$18M
Income Before Tax	-$1.9B	-$2.4B	-$25M	-$2.5B	$4.1B
Tax Expense	$1M	$2M	$231M	$22M	-$4M
Net Income	-$1.9B	-$2.4B	-$256M	-$2.5B	$4.1B
Net Margin	-125.8%	-105.7%	-5.6%	-36.1%	38.2%
EPS (Diluted)	$-37.20	$-40.64	$-3.49	$-25.20	$31.28
EBITDA	$843M	$715M	-$2.1B	-$2.4B	$1.3B
Shares Outstanding	51M	60M	73M	99M	134M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$1.5B	$1.8B	$1.8B	$1.9B	$2.2B	$2.6B	$2.5B	$3.5B
Cost of Revenue	$431M	$529M	$480M	$1.1B	$517M	$587M	$542M	$668M
Gross Profit	$1.1B	$1.3B	$1.3B	$806M	$1.7B	$2.0B	$2.0B	$2.9B
Gross Margin	71.0%	70.4%	73.1%	43.0%	76.4%	77.6%	78.7%	81.1%
R&D Expenses	$140M	$149M	$106M	$102M	$167M	$154M	$148M	$170M
SG&A Expenses	$1.2B	$1.3B	$1.3B	$1.3B	$1.5B	$1.5B	$1.5B	$2.1B
Operating Expenses	$1.4B	$1.5B	$1.4B	$1.4B	$1.7B	$1.7B	$1.6B	$2.2B
Operating Income	-$316M	-$215M	-$75M	-$550M	$9M	$352M	$347M	$627M
Operating Margin	-21.3%	-12.0%	-4.2%	-29.3%	0.4%	13.4%	13.7%	17.8%
Interest Expense	$21M	$20M	$18M	$15M	$65K	$4M	$2M	$3M
Income Before Tax	-$787M	-$7M	-$589M	-$1.1B	$918M	$1.1B	$723M	$1.4B
Tax Expense	$0	$11M	-$1M	$11M	$153M	$129M	$71M	-$355M
Net Income	-$787M	-$18M	-$588M	-$1.1B	$765M	$937M	$652M	$1.8B
Net Margin	-53.0%	-1.0%	-32.9%	-59.1%	34.9%	35.8%	25.7%	50.9%
EPS (Diluted)	$-9.20	$-0.18	$-5.65	$-11.00	$6.07	$7.00	$4.19	$13.64
EBITDA	$0	$0	$0	-$1.1B	$9M	$1.1B	$347M	$627M
Shares Outstanding	86M	98M	104M	101M	126M	126M	155M	132M

DMTRF OTC